We are live on
!
Find out more
B
Bailard Portfolio holdings
AUM
$4.35B
1-Year Est. Return
23.57%
This Fund
S&P 500
This Quarter
Est. Return
+8.25%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$2.89B
AUM Growth
+$197M
(+7.3%)
Cap. Flow
-$2.65M
Cap. Flow
% of AUM
-0.09%
Top 10 Holdings %
Top 10 Hldgs %
30.11%
Holding
781
New
94
Increased
203
Reduced
222
Closed
81
Top Buys
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$72M |
| 2 |
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
|
+$33.6M |
| 3 |
iShares MBS ETF
MBB
|
+$17.4M |
| 4 |
Apple
AAPL
|
+$6.96M |
| 5 |
Merck
MRK
|
+$5.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.56% |
| 2 | Healthcare | 8.54% |
| 3 | Financials | 7.27% |
| 4 | Consumer Discretionary | 5.22% |
| 5 | Communication Services | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Netflix
NFLX
$285B
| $3.46M | 0.12% |
65,560
-1,910
| -3% | -$97.6K |
|
152
Euronet Worldwide
EEFT
$2.97B
| $3.45M | 0.12% |
25,500
-5,275
| -17% | -$769K |
|
153
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.51B
| $3.42M | 0.12% |
77,257
-1,232
| -2% | -$52.8K |
|
154
Amgen
AMGN
$198B
| $3.35M | 0.12% |
13,758
+569
| +4% | +$140K |
|
|
SGMO
155
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $3.34M | 0.12% |
279,100
-43,500
| -13% | -$493K |
|
156
Thermo Fisher Scientific
TMO
$196B
| $3.26M | 0.11% |
6,460
-39
| -0.6% | -$18.4K |
|
157
AbbVie
ABBV
$448B
| $3.18M | 0.11% |
28,201
-1,677
| -6% | -$189K |
|
158
Zymeworks
ZYME
$1.72B
| $3.11M | 0.11% |
89,700
+26,200
| +41% | +$831K |
|
159
iShares Russell 2000 ETF
IWM
$81.6B
| $3.06M | 0.11% |
13,327
-352
| -3% | -$79.1K |
|
160
Humana
HUM
$47.7B
| $3M | 0.1% |
6,774
-59
| -0.9% | -$25.8K |
|
161
Northrop Grumman
NOC
$74.6B
| $2.92M | 0.1% |
8,045
| – | – |
|
162
Monster Beverage
MNST
$93.6B
| $2.87M | 0.1% |
62,804
-15,336
| -20% | -$720K |
|
163
Aflac
AFL
$62.9B
| $2.85M | 0.1% |
53,163
+5,704
| +12% | +$311K |
|
164
Citigroup
C
$222B
| $2.84M | 0.1% |
40,170
+5,898
| +17% | +$436K |
|
165
Oracle
ORCL
$362B
| $2.82M | 0.1% |
36,254
+10,608
| +41% | +$830K |
|
166
American Tower
AMT
$77.4B
| $2.81M | 0.1% |
10,383
-580
| -5% | -$148K |
|
167
Invesco S&P 500 Equal Weight ETF
RSP
$95.7B
| $2.8M | 0.1% |
18,598
| – | – |
|
168
Huntington Ingalls Industries
HII
$10.9B
| $2.75M | 0.1% |
13,056
-40
| -0.3% | -$8.52K |
|
169
Maravai LifeSciences
MRVI
$1.05B
| $2.72M | 0.09% |
65,140
-7,798
| -11% | -$302K |
|
170
iShares MSCI KLD 400 Social ETF
DSI
$5.28B
| $2.71M | 0.09% |
32,721
+475
| +1% | +$38.2K |
|
171
Schwab Emerging Markets Equity ETF
SCHE
$12.5B
| $2.7M | 0.09% |
82,120
+167
| +0.2% | +$5.42K |
|
|
172
Merck
MRK
$315B
| $2.69M | 0.09% |
34,605
-77,219
| -69% | -$5.74M |
|
173
Uber
UBER
$143B
| $2.66M | 0.09% |
52,985
-946
| -2% | -$49.4K |
|
|
FITB
174
Fifth Third Bancorp
FITB
$52.3B
| $2.65M | 0.09% |
69,352
+7,480
| +12% | +$299K |
|
175
HubSpot
HUBS
$10.5B
| $2.63M | 0.09% |
4,515
| – | – |
|
Similar funds
EC
SFM
NHC
EQF
CCM
NEI
Bailard's Q2 2021 Portfolio in Review
As of Q2 2021, Bailard held 781 positions worth $2.89B, up 7.3% from $2.7B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bailard's Q2 2021 filing shows 94 new, 203 increased, 222 reduced and 81 closed positions. Its largest new stake was First Trust Senior Loan Fund ETF: 335,979 shares worth $16.1M. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $72M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- Bailard's largest Q2 2021 buy was First Trust Senior Loan Fund ETF: 335,979 shares worth $16.1M.
- Bailard added most to Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF in Q2 2021, an estimated $74.6M increase.
- Bailard's biggest Q2 2021 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $72M.
- Bailard fully exited Nice in Q2 2021, selling an estimated $2.62M.
- Bailard's ten largest holdings make up 30% of its $2.89B portfolio in Q2 2021.
- Bailard opened 94 new positions and closed 81 in Q2 2021.
- Bailard's portfolio value rose 7.3% quarter-over-quarter to $2.89B.
Based on Bailard's 13F filing for Q2 2021, filed 13 Aug 2021.